We are live on ! Find out more
SEC

Seven Eight Capital Portfolio holdings

AUM $1.11B
1-Year Est. Return 29.48%
This Fund
S&P 500
This Quarter Est. Return
+1.9%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$559M
AUM Growth
-$480M
Cap. Flow
-$438M
Cap. Flow %
-78.37%
Top 10 Hldgs %
15.86%
Holding
756
New
216
Increased
66
Reduced
143
Closed
331

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$10.5M
2
C icon
Citigroup
C
+$10.5M
3
MSFT icon
Microsoft
MSFT
+$9.87M
4
OPTU
Optimum Communications Inc
OPTU
+$9.41M
5
AES icon
AES
AES
+$7.92M

Sector Composition

Rank Sector Weight
1 Technology 25.93%
2 Consumer Discretionary 17.95%
3 Healthcare 12.14%
4 Communication Services 8.7%
5 Financials 8.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLAY icon
626
Dave & Buster's
PLAY
$364M
-66,243
Closed -$2.54M
PLTK icon
627
Playtika
PLTK
$1.48B
-11,905
Closed -$329K
PNW icon
628
Pinnacle West Capital
PNW
$12.3B
-3,900
Closed -$282K
PPC icon
629
Pilgrim's Pride
PPC
$6.33B
-24,800
Closed -$721K
PPG icon
630
PPG Industries
PPG
$26.5B
-15,100
Closed -$2.16M
PRTA icon
631
Prothena Corp
PRTA
$444M
-14,800
Closed -$1.05M
PTON icon
632
Peloton Interactive
PTON
$2.82B
-19,394
Closed -$1.69M
PVH icon
633
PVH
PVH
$4.01B
-11,220
Closed -$1.15M
QCOM icon
634
Qualcomm
QCOM
$165B
-2,591
Closed -$334K
QLYS icon
635
Qualys
QLYS
$6.34B
-1,866
Closed -$208K
QNCX icon
636
Quince Therapeutics
QNCX
$28.2M
-11
Closed -$202K
QTWO icon
637
Q2 Holdings
QTWO
$3.97B
-20,110
Closed -$1.61M
RHI icon
638
Robert Half
RHI
$4.15B
-13,881
Closed -$1.39M
RKT icon
639
Rocket Companies
RKT
$39.9B
-119,903
Closed -$1.92M
RLX icon
640
RLX Technology
RLX
$2.37B
-14,759
Closed -$67K
RMD icon
641
ResMed
RMD
$32.4B
-919
Closed -$242K
RNG icon
642
RingCentral
RNG
$5.16B
-16,455
Closed -$3.58M
RPD icon
643
Rapid7
RPD
$726M
-11,273
Closed -$1.27M
RRC icon
644
Range Resources
RRC
$8.91B
-9,332
Closed -$211K
RS icon
645
Reliance Steel & Aluminium
RS
$21.5B
-2,546
Closed -$363K
RSI icon
646
Rush Street Interactive
RSI
$3B
-100,000
Closed -$1.92M
RYAAY icon
647
Ryanair
RYAAY
$31.8B
-8,020
Closed -$353K
SAGE
648
DELISTED
Sage Therapeutics
SAGE
-20,397
Closed -$904K
SBSW icon
649
Sibanye-Stillwater
SBSW
$7.02B
-78,969
Closed -$974K
SCI icon
650
Service Corp International
SCI
$11.6B
-66,253
Closed -$3.99M

Similar funds

Seven Eight Capital's Q4 2021 Portfolio in Review

As of Q4 2021, Seven Eight Capital held 756 positions worth $559M, down 46% from $1.04B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Seven Eight Capital withdrew a net $438M in Q4 2021, closing 331 positions and reducing 143 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $10.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Seven Eight Capital opened a new position in Allakos worth $3M.

  • Seven Eight Capital's largest Q4 2021 buy was Allakos: 306,723 shares worth $3M.
  • Seven Eight Capital added most to Mimecast Limited in Q4 2021, an estimated $6.07M increase.
  • Seven Eight Capital's biggest Q4 2021 reduction was Fidelity National Information Services, cutting an estimated $7.12M.
  • Seven Eight Capital fully exited Bristol-Myers Squibb in Q4 2021, selling an estimated $10.5M.
  • Seven Eight Capital's ten largest holdings make up 16% of its $559M portfolio in Q4 2021.
  • Seven Eight Capital opened 216 new positions and closed 331 in Q4 2021.
  • Seven Eight Capital's portfolio value fell 46% quarter-over-quarter to $559M.

Based on Seven Eight Capital's 13F filing for Q4 2021, filed 14 Feb 2022.